| Literature DB >> 16248285 |
Sin C Lau1, Daniela D Rosa, Gordon Jayson.
Abstract
sanofi-aventis (formerly Aventis) and Regeneron are developing systemic VEGF Trap, a soluble decoy receptor comprising portions of VEGF receptors 1 and 2, for the potential intravenous/subcutaneous treatment of cancer.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16248285
Source DB: PubMed Journal: Curr Opin Mol Ther ISSN： 1464-8431